The content of this website is intended for healthcare professionals only

Clinical articles

Our clinical articles provide comprehensive overviews of a large range of clinical topics and include helpful key learning points. Log your learning in your PDP tracker to claim CME credits.

For information on our editorial policy, click here.

You are viewing articles 1 - 15 of 732
A review of the definition, aetiology and assessment of delirium, including the role of good history taking, screening tools, examination and investigations.
A review of the causes, assessment and treatment of this common medical emergency that has a 10% hospital mortality rate
Lenalidomide now recommended for multiple myeloma in two pieces of NICE final draft guidance; MHRA issues class 2 medicines recall: Co-amoxiclav for oral suspension variants
Previous decision reversed for ocrelizumab for primary progressive multiple sclerosis in NICE final draft guidance; company-led drug alert issued for Macopharma intravenous infusion bags
A summary of the risk factors and management options for this very common condition
New and updated NICE guidelines published: recognition and referral of suspected neurological conditions and diagnosis and initial management of strokes and TIA; EMA recommends new long-lasting implant to treat opioid dependence
A clinical review of the classification, investigations, and management of a condition affecting about 600,000 people in UK. This article also includes considerations about pregnancy and the GP responsibility with the DVLA.
Accurately diagnosing a TIA can be quite difficult as the diagnosis is largely based on history from the patient. This clinical review includes the latest NICE guidance on imaging and the role of urgent carotid endarterectomy.
NICE final guidance recommends brentuximab vedotin for CD30‑positive cutaneous T‑cell lymphoma; MHRA issues medicines defect information for Ativan 4mg/1ml Solution for injection
Tildrakizumab and certolizumab pegol recommended for severe plaque psoriasis in NICE final guidance; AWMSG recommends blinatumomab for acute lymphoblastic leukaemia
Daratumumab plus bortezomib plus dexamethasone recommended by NICE within CDF for relapsed multiple myeloma; MHRA issues medicines defect information for Chloramphenicol 0.5% W/V Antibiotic Eye Drops
Abemaciclib with fulvestrant recommended for advanced breast cancer in NICE final draft guidance; EMA recommends new gene therapy to treat rare inherited blood condition
This article looks at symptom management and end-of-life care in COPD
Ertugliflozin recommended as monotherapy or with metformin for type 2 diabetes in NICE final guidance; EMA publishes Q&A on EU actions to prevent medicine shortages due to Brexit
Brigatinib recommended for ALK-positive lung cancer after crizotinib in NICE final guidance; increased risk of blood clots in lungs and death with higher dose of Xeljanz for rheumatoid arthritis reported
Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470